ByHeart has expanded its voluntary recall to include all Whole Nutrition Infant Formula cans and Anywhere Pack products amid an investigation by the Food and Drug Administration and other agencies of a multistate outbreak of infant botulism illnesses. The recall was previously limited to certain lots. As of Nov. 11, 15 infants had suspected or confirmed botulism and confirmed exposure to ByHeart Whole Nutrition infant formula, according to the FDA. Cases have been reported by 12 states.   
  
A company notice published by the FDA said that no unopened ByHeart product has tested positive for Clostridium botulinum spores or toxin, which can cause botulism. All products were proactively recalled to help the FDA and other investigators identify a root cause of the outbreak, which includes testing all batches of formula with an independent third-party laboratory. The FDA said it has been conducting a broader investigation with the Centers for Disease Control and Prevention into a recent spike of 84 infant botulism cases that began in August. The FDA recommended consumers with any ByHeart Whole Nutrition Infant Formula cans and Anywhere Pack products should discontinue use and dispose of them immediately. 

Headline
Angela Hewlett, M.D., professor of infectious diseases at the University of Nebraska Medical Center and medical director of the Nebraska Biocontainment Unit,…
Headline
The Food and Drug Administration has identified a Class I recall of reprocessed electrophysiology and ultrasound catheters by Medline Industries due…
Headline
The Administration for Strategic Preparedness and Response June 16 announced the launch of the Digital Stockpile and Manufacturing Response Network Challenge,…
Headline
President Trump signed an executive order May 29 that directs the Centers for Disease Control and Prevention and the Advisory Committee on Immunization…
Headline
The Centers for Disease Control and Prevention today released a report highlighting data on patients hospitalized during a 2025 measles outbreak centered in…
Headline
The Food and Drug Administration has issued an early alert for all heart pump controllers by Abiomed, which sent a correction notice to all customers with…